Sagimet Biosciences dropped 9% after Ascletis Pharma’s Phase 3 Denifanstat safety data focused on tolerability, not new ...

Researchers have developed two innovative tools to help us delve deeper into cell communication, offering spatial insight ...

The problem of antibiotic-resistant bacteria has many health experts worried. As disease-causing bacteria adapt to some of ...

When a high containment laboratory handling lethal pathogens stumbles, even briefly, it exposes how much of the country’s ...

A molecule produced by cancer cells can shield the brain from Alzheimer’s disease in mice. For decades, researchers have ...

Elucidata today announced the launch of the AI Lab, an initiative focused on advancing Artificial General Intelligence (AGI) across multiple research areas in Biomedical R&D, starting with one of the ...

Corvus Pharmaceuticals, Inc. jumps 165% on Phase 1 soquelitinib atopic dermatitis data; learn key efficacy, funding, and ...

Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways to cut years off R&D timelines and increase the chances of success amid rising costs ...

OpenAI continues its push into healthcare with the launch of ChatGPT Health, a new feature that connects its artificial intelligence chatbot with users' medical records and wellness apps for more ...

As more AI workloads are scaled into energy-intensive data centers, the pressure on power supply chains will intensify. Lenovo's Simone Larsson told CNBC there's going to be a "tipping point" where ...

A simple story has taken hold in American politics: Big Tech is consuming vast amounts of electricity to power artificial intelligence, and ordinary households are paying the price. It's a tidy ...